House Republicans Aim To Yank Tax Credits For Orphan Drugs
House Republicans want to repeal federal tax credits that have helped spur a boom in orphan drugs for rare diseases.
Health Industry
2,401 - 2,420 of 3,939 Results
-
-
Timeline: Insulin Market Under Scrutiny
A flurry of federal and state probes have targeted insulin manufacturers and pharmacy benefit managers — middlemen in the prescription drug-pricing pipeline. Here, we connect the legal dots.
-
Flurry Of Federal And State Probes Target Insulin Drugmakers And Pharma Middlemen
Over the past two years, a powerful federal prosecutor and several state attorneys general have launched investigations related to diabetes drugs.
-
Millennials Embrace Nursing Profession — Just In Time To Replace Baby Boomers
Nursing generally offers stable earnings and low unemployment, which likely sounds good to young adults who came of age during the Great Recession.
-
‘No One Is Coming’: Hospice Patients Abandoned At Death’s Door
U.S. hospice agencies promise to be available around-the-clock to help patients dying in their homes. But a Kaiser Health News investigation shows that in an alarming number of cases, that promise is broken.
By JoNel Aleccia and Melissa Bailey -
Federal Judge Denies Bid To Force Feds To Resume ACA Subsidies
U.S. District Judge Vince Chhabria said the vast majority of states have already prepared for the termination of the payments and already devised responses that give consumers better coverage.
By Ngoc Nguyen -
Treatment Overkill
So Much Care It Hurts: Unneeded Scans, Therapy, Surgery Only Add To Patients’ Ills
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
By Liz Szabo -
Desperate Quest For Herpes Cure Launched ‘Rogue’ Trial
Patients flocked to researcher who ignored usual patient protections, as university claimed ignorance.
-
Hospitals Step In To Help House The Homeless. Will It Make A Difference?
They say it will help reduce unnecessary ER visits and ensure better follow-up care. It’s also good P.R., and helps them meet their obligations to provide benefits to the community in exchange for significant tax breaks.
-
Chasing Millions In Medicaid Dollars, Hospitals Buy Up Nursing Homes
The strategy has been used mostly in Indiana, where many county-owned hospitals purchased or leased nursing homes to take advantage of a wrinkle in Medicaid payment rules and augment federal reimbursements.
-
On Back Roads Of Appalachia’s Coal Country, Mental Health Services Are As Rare As Jobs
Long commutes and scarcity of providers make it hard for patients who need counseling or psychiatric care.
-
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
By Liz Szabo -
Anthem Eases Up On Premium Hikes After State Scrutiny
After regulators questioned Anthem’s forecast for medical costs, the company agreed to reduce rate hikes on its individual and small-business health plans next year, saving customers an estimated $114 million.
By Chad Terhune -
In Oregon, End-of-Life Wishes Are Just A Click Away
A new link creates two-way access to the state registry that documents the type of medical care sick and frail patients want — or refuse.
-
New Law Challenges ‘Evils’ Of Pharma Profits, California Governor Claims
Gov. Jerry Brown signed the measure, which takes effect next year and will require drug companies to publicly justify big price increases.
-
Training New Doctors Right Where They’re Needed
Eight teaching centers in California aim to train and retain doctors in medically underserved areas such as California’s Central Valley. They are among 57 such institutions across the country that may soon receive a boost in funding from Congress.
-
Eyes Fixed On California As Governor Ponders Inking Drug Price Transparency Bill
"If it gets signed by this governor, it's going to send shock waves throughout the country,” one legislator says. Pharma has spent $16.8 million lobbying against this bill and other drug laws in California.
-
Las Vegas Faced a Massacre. Did It Have Enough Trauma Centers?
Hospitals view adding trauma care as a potential profit tool, but experts say having more centers does not necessarily improve the system’s ability to respond to a mass casualty event.
By Julie Appleby and Phil Galewitz -
Heart Device Failure: Medicare Spent $1.5B Over 10 Years To Replace Defective Implants
The inspector general at Health and Human Services says defective pacemakers or defibrillators had to be replaced from 2005 through 2014, costing Medicare $1.5 billion.
By Fred Schulte and Christina Jewett -
Latest Scandal Too Much For HHS Secretary Tom Price. He’s Out.
Tom Price resigned from running the Department of Health and Human Services after a series of news stories detailing how he tallied more than $400,000 in private plane travel paid for by taxpayers.
By Julie Rovner